Endocannabinoid Signaling in Hypothalamic-Pituitary-Adrenocortical Axis Recovery Following Stress: Effects of Indirect Agonists and Comparison of Male and Female Mice

作者: Christopher J. Roberts , Kara L. Stuhr , Michael J. Hutz , Hershel Raff , Cecilia J. Hillard

DOI: 10.1016/J.PBB.2013.11.026

关键词:

摘要: Studies in male rodents have shown that stress-induced increases circulating corticosterone are increased by both CB1 receptor (CB1R) antagonist treatment and genetic deletion. The purposes of the current study were to determine whether female mice respond same manner as males, indirect CB1R agonists accelerate return baseline. In agreement with earlier studies, null rimonabant-treated had significantly 30 min following end a restraint episode compared wild type vehicle-treated, respectively. Females treated rimonabant higher vehicle. However, concentrations not different between females at recovery, although 90 recovery. Female exhibited greater serum binding capacity for than type. monoacylglycerol lipase inhibitor, JZL184, attenuated offset male, recovery Male JZL184 120 even absence restraint. no effect on mice. fatty acid amide hydrolase URB597, did affect responses or female, These data suggest 2-arachidonoylglycerol is primary endocannabinoid involved regulation HPA axis from stress. support role endocannabinoid-CB1R signaling response stress life-long loss undergo compensatory changes minimize impact corticosterone.

参考文章(56)
I S McGregor, J C Arnold, Cannabis reward: biased towards the fairer sex? British Journal of Pharmacology. ,vol. 152, pp. 562- 564 ,(2007) , 10.1038/SJ.BJP.0707469
M. M. Ibrahim, H. Deng, A. Zvonok, D. A. Cockayne, J. Kwan, H. P. Mata, T. W. Vanderah, J. Lai, F. Porreca, A. Makriyannis, T. P. Malan, Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS Proceedings of the National Academy of Sciences of the United States of America. ,vol. 100, pp. 10529- 10533 ,(2003) , 10.1073/PNAS.1834309100
Steven G. Kinsey, Scott T. O'Neal, Jonathan Z. Long, Benjamin F. Cravatt, Aron H. Lichtman, Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay. Pharmacology, Biochemistry and Behavior. ,vol. 98, pp. 21- 27 ,(2011) , 10.1016/J.PBB.2010.12.002
Benjamin F. Cravatt, Dan K. Giang, Stephen P. Mayfield, Dale L. Boger, Richard A. Lerner, Norton B. Gilula, Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature. ,vol. 384, pp. 83- 87 ,(1996) , 10.1038/384083A0
B Mateos, E Borcel, R Loriga, W Luesu, V Bini, R Llorente, MP Castelli, M-P Viveros, Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB1 cannabinoid receptors Journal of Psychopharmacology. ,vol. 25, pp. 1676- 1690 ,(2011) , 10.1177/0269881110370503
Tatyana Buynitsky, David I. Mostofsky, Restraint stress in biobehavioral research: Recent developments. Neuroscience & Biobehavioral Reviews. ,vol. 33, pp. 1089- 1098 ,(2009) , 10.1016/J.NEUBIOREV.2009.05.004
Kenneth M. Johnson, William L. Dewy, Katherine S. Ritter, Jacquieline S. Beckner, Cannabinoid effects on plasma corticosterone and uptake of 3H-corticosterone by mouse brain European Journal of Pharmacology. ,vol. 47, pp. 303- 310 ,(1978) , 10.1016/0014-2999(78)90238-8
Liana Fattore, Paola Fadda, Walter Fratta, Sex differences in the self-administration of cannabinoids and other drugs of abuse. Psychoneuroendocrinology. ,vol. 34, ,(2009) , 10.1016/J.PSYNEUEN.2009.08.008